A 2022 survey found that 63 percent of Canadian individuals indicated a lack of staff was the biggest problem facing the national healthcare system. Access to treatment and/or long waiting times were also considered to be pressing issues. This statistic reveals the share of individuals who said select problems were the biggest facing the health care system in Canada in 2022.

In 2023, ** percent of surveyed respondents in Canada reported that loss of human interaction with healthcare providers was a major concern around the use of artificial intelligence in health care systems. Meanwhile, a further ** percent of respondents said they were concerned about liability related to care decisions made using AI.

Health systems in Canada struggle to generate and use knowledge to improve equity-centred quadruple aim measures, resulting in care that is misaligned with local contexts. Learning Health Systems (LHS) offer a solution by aligning real-time evidence, informatics, patient-provider partnerships, and institutional strategies to support continuous improvements in care. Despite their potential, LHS initiatives in Canada remain siloed and lack harmonized leadership, knowledge exchange, and capacity building. To address these gaps, the Learning Health Hub was established to foster collaboration, disseminate best practices, and enhance collective capacity for LHS in Canada. In June 2024, the Learning Health Hub hosted its inaugural virtual symposium. This event brought together partners, researchers, health professionals, system operators, and policymakers from across Canada interested in LHS work. The symposium aimed to map assets and build momentum for larger-scale impact in LHS. Participants engaged in generative activities to define challenges and co-create solutions, resulting in the identification of key learning priorities. Three learning themes were identified: Patient, Caregiver, and Community Partnership; Enabling Environments; and Benchmarking and Evaluation. By advancing these themes, the Learning Health Hub aims to drive meaningful, sustainable change and improve healthcare quality and outcomes.

The Canadian Community Health Survey (CCHS) is a cross-sectional survey that collects information related to health status, health care utilization and health determinants for the Canadian population. The CCHS operates on a two-year collection cycle. The first year of the survey cycle “.1” is a large sample, general population health survey, designed to provide reliable estimates at the health region level. The second year of the survey cycle “.2” is a smaller survey designed to provide provincial level results on specific focused health topics. This Microdata File contains data collected in Cycle 1.2 Mental Health and Well-Being. This cycle mainly measures aspects linked to the mental health of Canadians. The primary objectives of the CCHS Mental Health and Well-being are to: Provide timely, reliable, cross-sectional estimates of mental health determinants, mental health status and mental health system utilization across Canada Determine prevalence rates of selected mental disorders to assess the impact of burden of illness Juxtapose access and utilization of mental health services with respect to perceived needs Assess the disabilities associated with mental health problems to individuals and society Information was collected between May 2002 and December 2002, for the ten provinces. Cycle 1.2 collects responses from persons aged 15 or older, living in private occupied dwellings. Excluded from the sampling frame are individuals living on Indian Reserves and on Crown Lands, Health Care institution residents, full-time members of the Canadian Armed Forces, and residents of certain remote regions.

In 1991, the National Task Force on Health Information cited a number of issues and problems with the health information system. To respond to these issues, the Canadian Institute for Health Information (CIHI), Statistics Canada and Health Canada joined forces to create a Health Information Roadmap. From this mandate, the Canadian Community Health Survey (CCHS) was conceived. The CCHS is a cross-sectional survey that collects information related to health status, health care utilization and health determinants for the Canadian population. The survey is offered in both official languages. It relies upon a large sample of respondents and is designed to provide reliable estimates at the health region level every 2 years. The primary use of the CCHS data is for health surveillance and population health research. The data presented here is by age group and sex, for Canada, provinces, territories and health regions (2017 boundaries).

BackgroundIn Canada, cannabis legalization altered the way that the public can access cannabis for medical purposes. However, Canadians still struggle with finding healthcare professionals (HCPs) who are involved in medical cannabis counselling and authorization. This raises questions about the barriers that are causing this breakdown in care. Our study explored the perceptions of primary care providers regarding cannabis in their practice.MethodsSemi-structured interviews were conducted by Zoom with HCPs in Newfoundland and Labrador (NL) to discuss their experiences with medical and non-medical cannabis in practice. Family physicians and nurse practitioners who were practicing in primary care in NL were included. The interview guide and coding template were developed using the Theoretical Domains Framework (TDF). A thematic analysis across the TDF was then conducted.ResultsTwelve participants with diverse demographic backgrounds and experience levels were interviewed. Five main themes emerged including, knowledge acquisition, internal influences, patient influences, external HCP influences, and systemic influences. The TDF domain resulting in the greatest representation of codes was environmental context and resources.InterpretationThe findings suggested that HCPs have significant knowledge gaps in authorizing medical cannabis, which limited their practice competence and confidence in this area. Referring patients to cannabis clinics, while enforcing harm-reduction strategies, was an interim option for patients to access cannabis for medical purposes. However, developing practice guidelines and educational resources were suggested as prominent facilitators to promote medical cannabis authorization within the healthcare system.

In 1991, the National Task Force on Health Information cited a number of issues and problems with the health information system. To respond to these issues, the Canadian Institute for Health Information (CIHI), Statistics Canada and Health Canada joined forces to create a Health Information Roadmap. From this mandate, the Canadian Community Health Survey (CCHS) was conceived. The CCHS is a cross-sectional survey that collects information related to health status, health care utilization and health determinants for the Canadian population. The survey is offered in both official languages. It relies upon a large sample of respondents and is designed to provide reliable estimates at the health region level every 2 years. The CCHS has the following objectives: - Support health surveillance programs by providing health data at the national, provincial and intra-provincial levels; - Provide a single data source for health research on small populations and rare characteristics; - Timely release of information easily accessible to a diverse community of users; - Create a flexible survey instrument that includes a rapid response option to address emerging issues related to the health of the population. The CCHS produces an annual microdata file and a file combining two years of data. The CCHS collection years with both consistent design and consistent population representation can also be combined by users to examine populations or rare characteristics. The primary use of the CCHS data is for health surveillance and population health research. Federal and provincial departments of health and human resources, social service agencies, and other types of government agencies use the information collected from respondents to monitor, plan, implement and evaluate programs to improve the health of Canadians. Researchers from various fields use the information to conduct research to improve health. Non-profit health organizations and the media use the CCHS results to raise awareness about health, an issue of concern to all Canadians. The survey began collecting data in 2001 and was repeated every two years until 2005. Starting in 2007, data for the Canadian Community Health Survey (CCHS) were collected annually instead of every two years. While a sample of approximately 130,000 respondents were interviewed during the reference periods of 2001, 2003 and 2005, the sample size was changed to 65,000 respondents each year starting in 2007. The CCHS has undergone two major redesigns. The first in 2015 reviewed the sampling methodology, adopted a new sample frame, modernized and updated its health content, and reviewed the target population. The second in 2022, further reviewed and updated the content of the survey as well as transitioned it to an online electronic questionnaire (EQ) that was available for direct self reporting by selected respondents. Consultations were held with federal, provincial and territorial share partners, health region authorities and academics for both redesigns. As a result of these redesigns and major changes to collection and sampling approaches as well as content updates, caution should be taken when comparing data from previous cycles to data released for the 2015 and 2021 and for data released 2022 and onwards.

Canada Endoscopy Devices Market size was valued to be USD 1.29 Billion in the year 2023 and it is expected to reach USD 2.01 Billion in 2031, at a CAGR of 5.7% over the forecast period of 2024 to 2031.

Canada Endoscopy Devices Market Dynamics

The key market dynamics that are shaping the Canada Endoscopy Devices Market include:

Key Market Drivers

Rising Gastrointestinal Diseases: The growing prevalence of gastrointestinal problems in Canada is driving up demand for endoscopic procedures. According to the Canadian Digestive Health Foundation, approximately 20 million Canadians suffer from digestive issues each year, with colorectal cancer affecting one in every fourteen people in their lifetime. The foundation also claims that digestive diseases cost the Canadian healthcare system more than $18 billion each year in direct and indirect expenditures.

This survey provides data on the lifestyle and health of Canadians, complementing existing administrative data bases. Major areas of coverage include risk factors, health status, and consequences. Risks to future health of three main types are identified and probed in the CHS. They are lifestyle, bio-medical and environmental. Lifestyle, in particular, lends itself to measurement in a household survey. Risks have an impact on future health, but, since the time element is missing from a cross-sectional survey, the CHS was restricted to examining the distribution of known hazards. Health status - only partially the outcome of earlier risk exposure - has positive and negative dimensions, which were measured for both the physical and emotional facets of health. Because morbidity statistics are most commonly derived from health records which report a single episode rather than entire histories, it is impossible to assess the personal burden of ill health, especially for those problems which do not reach the health care system. The CHS rectifies the situation by identifying health problems and their consequences for each individual in the sample, and using these to evaluate the impact of ill health.

Abstract copyright UK Data Service and data collection copyright owner. To collect data at an international level on the use of medical care and its relation to characteristics of both the population and the prevailing health care systems. Main Topics: Variables Questions covered the following areas: Psychosocial and demographic characteristics, e.g. health related attitudes, family composition, income, education and locus of responsibility for health within the family. Levels of ill-health and perceived morbidity, reasons for use of health services, e.g. restricted activity days, bed disability days, chronic illness and disability, selected indicator conditions of pyschobiological dysfunction, and dental and vision problems. Use of health services provided by physicians, hospitals, dentists, and selected categories of non-physician health care personnel, and use of prescribed and non-prescribed medicines. One-stage stratified or systematic random sample Grande Prairie, Saskatchewan (Canada); Northwestern Vermont, Baltimore (U.S.); Buenos Aires (Argentina); Liverpool (U.K.); Helsinki (Finland); Lodz (Poland); Banat, Rijeka (Yugoslavia). A simple random sample only was drawn from Fraser and Jersey (British Columbia, Canada). Face-to-face interview

Snapshot img

Hospital Furniture Market Size 2024-2028

The hospital furniture market size is forecast to increase by USD 8 billion, at a CAGR of 8.06% between 2023 and 2028.

The market is experiencing significant growth due to the increasing international accreditation of hospitals. This trend is driven by the increasing emphasis on providing high-quality patient care and facilities that meet international standards. However, this market also faces challenges, primarily from the growing geriatric population and the limited sustainability of smaller companies. The geriatric population's increasing need for specialized furniture and medical equipment is putting pressure on hospitals to invest in more comfortable and accessible solutions. Meanwhile, The market's competitive landscape is fragmented, with numerous small companies struggling to remain profitable. These companies face challenges in meeting the demand for high-quality, cost-effective solutions while also competing with larger, more established players.
Companies seeking to capitalize on market opportunities must focus on innovation, sustainability, and cost-effectiveness to differentiate themselves and meet the evolving needs of hospitals and their patients. Additionally, collaborations and partnerships with healthcare providers and industry associations can help smaller companies gain market share and build a strong brand presence. Overall, the market presents both opportunities and challenges, requiring strategic planning and a focus on meeting the unique needs of healthcare providers and their patients.

What will be the Size of the Hospital Furniture Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, with dynamic market activities shaping its landscape. HVAC systems are integrated into hospital designs to ensure optimal indoor air quality, enhancing patient and staff comfort. Work flow optimization and supply chain management are crucial for efficient operations, while infection prevention remains a top priority. Medical cabinets and medical carts facilitate easy access to essential medical equipment, and hospital beds and operating tables are designed for patient comfort and safety. Space planning is essential for maximizing efficiency in healthcare facilities, with sterilization equipment and infection control measures integrated into the design.

Steel furniture offers durability and strength, while anesthesia machines and biomedical engineering solutions enable advanced medical procedures. Patient handling equipment, including patient lifts and overbed tables, ensures safe patient transfer and positioning. Customizable furniture caters to the unique needs of various sectors, such as nursing homes and rehabilitation centers. Antimicrobial coatings and material science advancements contribute to hygiene standards, while fire safety and weight capacity are critical considerations. Staff training and regulatory compliance are ongoing priorities, ensuring the effective use of all furniture and equipment. Modular furniture offers flexibility in design and layout, while iv poles and storage cabinets cater to the diverse needs of healthcare facilities.

Electrical systems and medical imaging systems are integrated into the furniture design for seamless functionality. Patient comfort and patient monitors are essential for positive patient experiences, with patient lifts and nursing home furniture designed to cater to the specific needs of elderly patients. The market is characterized by continuous innovation and adaptation to meet the evolving needs of healthcare facilities and patients. From HVAC systems to medical imaging systems, every aspect of hospital furniture is designed with patient safety, staff efficiency, and infection prevention in mind. The ongoing integration of technology and material science advancements ensures that hospital furniture remains a vital component of modern healthcare facilities.

How is this Hospital Furniture Industry segmented?

The hospital furniture industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Physician furniture
  Patient furniture
  Staff furniture


Product

  Hospital beds
  Specialty medical chairs and tables
  Others


Geography

  North America

    US
    Canada


  Europe

    Germany
    UK


  APAC

    China


  Rest of World (ROW)

By Application Insights

The physician furniture segment is estimated to witness significant growth during the forecast period.

The healthcare sector's evolution has led to an increased focus on creating advanced and comforta

Snapshot img

Medical X-Ray Films Market Size 2024-2028

The medical X-ray films market size is forecast to increase by USD 110.2 million, at a CAGR of 2.1% between 2023 and 2028. The market is experiencing notable growth driven by the rising prevalence of chronic conditions like heart disease, bone injuries, and tumors, which has increased the demand for X-ray imaging. Technological advancements in X-ray systems further support this growth by enabling quicker and more precise diagnoses.

Furthermore, the growing number of surgeries, including heart surgeries, knee replacements, and dental surgeries, is fueling the demand for X-ray films. However, the market faces challenges from stringent regulations and the shift towards digital imaging solutions, which may limit the growth of the X-ray films market. Despite these challenges, the market is expected to continue its growth trajectory due to the high demand for X-ray films in various medical applications, such as the diagnosis of pneumonia and other respiratory conditions.

Market Analysis

Request Free Sample

X-ray technology plays a crucial role in the diagnosis and treatment of various medical conditions, including neurological problems, cancer, cardiac diseases, bone-related issues, and chronic diseases. Radiography tests using x-ray imaging procedures are commonly used in healthcare to examine the human body and identify potential issues. Digital x-ray systems have largely replaced traditional analog equipment due to their superior image quality and efficiency. The aging population and increasing prevalence of chronic diseases, such as arthritis, orthopedic diseases, and dental problems, have fueled the demand for medical diagnostic equipment, including x-ray systems. Digital radiography systems have gained popularity due to their ability to produce high-quality images, reduce radiation exposure, and enable quicker diagnosis.

Moreover, government spending on healthcare and advancements in technology continue to drive the growth of the x-ray film market. X-ray films are essential components of x-ray systems, used to capture images of the body for further analysis. These films are used in various medical diagnostic imaging procedures, such as heart surgeries, knee replacements, bone injuries, tumors, pneumonia, and other medical conditions. X-ray film processors are used to develop these films, providing healthcare professionals with clear and accurate images for effective diagnosis and treatment.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Diagnostic Centers
  Hospitals
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  APAC

    China


  South America



  Middle East and Africa

By Type Insights

The diagnostic centers segment is estimated to witness significant growth during the forecast period. In the healthcare sector, diagnostic centers play a significant role in providing medical imaging services, including X-ray examinations. These centers are categorized into three sizes: large, medium, and small, based on the volume of diagnostic procedures performed. Large diagnostic centers, often affiliated with multiple hospitals, offer cost-effective solutions for X-ray analysis. They utilize advanced medical diagnostic equipment, such as X-ray film processors, to ensure accurate results. These centers electronically transmit the findings to hospitals, thereby reducing medical expenses and shortening the turnaround time for result delivery. Medium-sized hospitals, with limited budgets, may find the acquisition of expensive X-ray systems a financial burden.

Additionally, the use of X-ray films, with their emulsion layer and base, remains crucial in diagnosing various conditions, such as Orthopedic diseases like Arthritis and Dental problems. Government spending on healthcare infrastructure and technology continues to drive the demand for advanced medical diagnostic equipment, including X-ray systems.

Get a glance at the market share of various segments Request Free Sample

The diagnostic Centers segment was valued at USD 456.40 million in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The North American region led the market in 2023, with the US being its major contributor. The region's growth is attributed to increasing healthcare expenditures, a rising prevalence of c

This Voice of the People poll seeks the opinions of Canadians, on predominantly economic, political, and social issues. The questions ask opinions of corruption in society, incidences of bribery, education system, health care, and opinion of international organizations, including humanitarian aid organizations. There are also questions on other topics of interest such as internet use, politics, foreign investment in Canada, women and equal rights, United States' foreign policy, and donations to charity. The respondents were also asked questions so that they could be grouped according to geographic and social variables. Topics of interest include: global issues; neutrality of international humanitarian efforts; health care; politics; education system; bribery; corruption; global institutions; and women. Basic demographic variables are also included.

While smaller in scale than their US counterparts, brand name pharmaceutical manufacturers in Canada play a pivotal role in the Canadian healthcare system. Canadians rely heavily on prescription medications. The country ranks among the top per capita drug expenditure globally, positioning manufacturers to benefit from strong consumer demand and public health initiatives. Driving factors behind rising spending on brand name drugs in Canada recently include an aging demographic, broader health coverage through provincial plans, approvals for new therapies and advances in specialized treatments for conditions like rare genetic disorders and cancer. Despite this, branded manufacturers have struggled against biosimilar competition, which provides buyers with more affordable options. In all, Brand name pharmaceutical manufacturers are navigating a rapidly evolving regulatory environment. A critical change potentially impacting the brand name pharma landscape is updates from the Patent Medicine Prices Review Board (PMPRB), which aims to reduce excessive pharmaceutical prices. Alongside other initiatives, these reforms would impact manufacturer pricing strategies significantly, mirroring the global trend of restricting drug price escalation. Despite these potential hurdles, other initiatives stand to strengthen domestic pharmaceutical production, including a new pathway to expedite access to innovative therapies and an adjustment to the Patent Act, which will compensate pharmaceutical companies that face unreasonable delays. While brand name pharma companies will have to adapt to an evolving environment, demographic changes and medical and tech advances will move the industry forward. Rising investments in R&D will bring new, innovative therapies to market; federal and provincial support surrounding treatments for rare conditions and innovation will also support manufacturers. At the same time, an increasing prevalence of chronic illness and a growing number of over 65 adults will support a steep demand for prescription drugs. Consolidation activity will continue as incumbents look for ways to diversify pipelines, access new technologies or reach new markets to offset pressures from patent cliffs and regulatory changes. Revenue will expand, rising at a CAGR of 2.1% to reach an estimated $8.3 billion in 2029.

Molt Mouth Gag Market Outlook

The global Molt Mouth Gag market size was valued at USD 200 million in 2023 and is expected to reach approximately USD 320 million by 2032, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period. The increasing prevalence of dental disorders and a rising number of dental procedures are key growth factors contributing to this market's expansion.

One of the primary growth drivers for the Molt Mouth Gag market is the surge in dental procedures worldwide. As the global population ages, the incidence of dental ailments such as periodontitis, tooth decay, and oral cancer is on the rise, necessitating a higher number of dental surgeries and treatments. Consequently, the demand for efficient and reliable dental instruments, including Molt Mouth Gags, is increasing. This trend is particularly evident in developed nations where healthcare infrastructure is advanced, and there is a greater awareness of dental health.

Another significant factor propelling market growth is technological advancements in dental tools and equipment. Innovations such as the development of ergonomic and patient-friendly Molt Mouth Gags have enhanced the efficiency and comfort of dental procedures. These advancements not only improve patient outcomes but also streamline dental procedures for clinicians. The integration of high-quality materials that increase product durability and sterility also contributes to the growing adoption of Molt Mouth Gags in various medical settings.

Growing investments in healthcare infrastructure, especially in emerging economies, further enhance market growth. Governments and private entities are increasingly allocating funds to improve dental care facilities, thereby boosting the demand for dental instruments. Training programs and awareness campaigns about oral hygiene are also instrumental in driving the market. These initiatives help in educating the population about the importance of dental health, leading to more frequent visits to dental clinics and hospitals, which in turn escalates the utilization of Molt Mouth Gags.

Regionally, North America dominates the Molt Mouth Gag market due to its advanced healthcare system and high healthcare expenditure. Countries like the United States and Canada have a well-established dental care infrastructure, with a significant focus on research and development in dental tools. Europe follows closely with significant contributions from countries like Germany, France, and the UK. However, rapid growth is expected in the Asia Pacific region, driven by increasing healthcare investments in countries such as China and India, coupled with a growing awareness of dental health.

Product Type Analysis

The Molt Mouth Gag market is segmented by product type into Adult Molt Mouth Gag and Pediatric Molt Mouth Gag. The adult segment holds a larger share of the market, primarily due to the higher incidence of dental procedures in adults. The increasing prevalence of dental issues such as gingivitis, cavities, and oral cancer among adults has led to a higher demand for Adult Molt Mouth Gags. Additionally, the aging population, which is more prone to dental problems, further fuels the demand in this segment.

Pediatric Molt Mouth Gags, while constituting a smaller share of the market, are witnessing steady growth. This growth is attributed to the rising awareness about pediatric dental care and the increasing number of dental procedures performed in younger patients. The focus on preventive dental care in children has led to early diagnosis and treatment of dental problems, necessitating the use of specialized pediatric dental instruments. Manufacturers are also innovating with more ergonomic and child-friendly designs to make dental procedures less daunting for children.

The demand for customized and patient-specific Molt Mouth Gags is also emerging as a notable trend within the product type segment. Dental professionals are increasingly seeking instruments tailored to the specific needs of their patients, whether adult or pediatric, to enhance the effectiveness and comfort of dental procedures. This customization trend is expected to further drive market growth in the coming years.

Moreover, the introduction of disposable Molt Mouth Gags, designed to reduce the risk of cross-contamination and infection, is gaining traction. These disposable instruments are particularly popular in pediatric settings, where maintaining high levels of hygiene is crucial. The increased focus on infection control measures

In 1991, the National Task Force on Health Information cited a number of issues and problems with the health information system. To respond to these issues, the Canadian Institute for Health Information (CIHI), Statistics Canada and Health Canada joined forces to create a Health Information Roadmap. From this mandate, the Canadian Community Health Survey (CCHS) was conceived. The CCHS is a cross-sectional survey that collects information related to health status, health care utilization and health determinants for the Canadian population. The survey is offered in both official languages. It relies upon a large sample of respondents and is designed to provide reliable estimates at the health region level every 2 years. The CCHS has the following objectives: * Support health surveillance programs by providing health data at the national, provincial and intra-provincial levels; * Provide a single data source for health research on small populations and rare characteristics; * Timely release of information easily accessible to a diverse community of users; * Create a flexible survey instrument that includes a rapid response option to address emerging issues related to the health of the population. The CCHS produces an annual microdata file and a file combining two years of data. The CCHS collection years can also be combined by users to examine populations or rare characteristics. The primary use of the CCHS data is for health surveillance and population health research. Federal and provincial departments of health and human resources, social service agencies, and other types of government agencies use the information collected from respondents to monitor, plan, implement and evaluate programs to improve the health of Canadians. Researchers from various fields use the information to conduct research to improve health. Non-profit health organizations and the media use the CCHS results to raise awareness about health, an issue of concern to all Canadians. The survey began collecting data in 2001 and was repeated every two years until 2005. Starting in 2007, data for the Canadian Community Health Survey (CCHS) were collected annually instead of every two years. While a sample of approximately 130,000 respondents were interviewed during the reference periods of 2001, 2003 and 2005, the sample size was changed to 65,000 respondents each year starting in 2007. In 2012, CCHS began work on a major redesign project that was completed and implemented for the 2015 cycle. The objectives of the redesign were to review the sampling methodology, adopt a new sample frame, modernize the content and review the target population. Consultations were held with federal, provincial and territorial share partners, health region authorities and academics. As a result of the redesign, the 2015 CCHS has a new collection strategy, is drawing the sample from two different frames and has undergone major content revisions. With all these factors taken together, caution should be taken when comparing data from previous cycles to data released for the 2015 cycle onwards.

Snapshot img

Dementia And Movement Disorder Treatment Market Size 2025-2029

The dementia and movement disorder treatment market size is forecast to increase by USD 14.43 billion at a CAGR of 9% between 2024 and 2029.

The market is experiencing significant growth, driven primarily by the increasing geriatric population, who are more susceptible to these neurological conditions. As the global population ages, the prevalence of neurological disorders such as dementia and movement disorders is rising, creating a substantial demand for effective treatments. A second key driver is the emergence of biomarkers, which are revolutionizing the diagnosis and treatment of these conditions. However, the high cost of neurological disorders treatment poses a significant challenge for both patients and healthcare systems. Despite this, opportunities exist for companies to innovate and develop more affordable and effective treatments, particularly through the use of advanced technologies and personalized medicine approaches.
Navigating this complex market requires a deep understanding of the latest research and development trends, as well as a strategic approach to addressing the challenges of cost and accessibility. Companies seeking to capitalize on these opportunities must stay abreast of the latest scientific advancements and regulatory developments, while also building strong partnerships with key stakeholders in the healthcare ecosystem. Gene therapy and drug therapy are emerging as promising treatments for various neurological conditions, including spinal muscular atrophy and multiple sclerosis.

What will be the Size of the Dementia And Movement Disorder Treatment Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

Diagnostic imaging plays a crucial role in early diagnosis and disease management, enabling healthcare providers to develop personalized treatment plans for patients. The market encompasses a range of interventions aimed at managing cognitive decline and motor impairments. Cognitive assessment plays a crucial role in diagnosing and monitoring disease progression, while end-of-life care focuses on improving the quality of life for patients and their families. Treatment guidelines prioritize a multidisciplinary approach, incorporating lifestyle modifications, ethical considerations, and psychosocial support. Communication aids and behavioral interventions are essential for maintaining patient engagement and enhancing caregiver communication. Speech difficulties, a prevalent issue in conditions such as Huntington's disease and Parkinson's disease, are being addressed through speech therapy and cognitive rehabilitation. Cerebrospinal fluid analysis and genetic testing offer insights into disease mechanisms, informing personalized treatment plans. Brain imaging techniques, such as PET scans and MRI scans, facilitate early diagnosis and functional capacity assessment.
Cholinesterase inhibitors and NMDA receptor antagonists represent pharmacological interventions, while brain imaging, adaptive equipment, environmental modifications, and remote monitoring enable non-pharmacological approaches. Prevention strategies, including caregiver burden reduction and economic impact mitigation, are vital for addressing the social and economic consequences of these disorders. Ethical considerations and social impact are increasingly important in the context of dementia and movement disorder treatment, as the global population ages and the burden on healthcare systems grows. The market is characterized by ongoing research and innovation, with a focus on improving patient outcomes and enhancing caregiver support.

How is this Dementia And Movement Disorder Treatment Industry segmented?

The dementia and movement disorder treatment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Application

  Movement disorders
  Progressive dementia
  Progressive dementia with neurological abnormality (PDNA)


Drug Class

  MAO inhibitors
  Acetylcholinesterase inhibitors
  Glutamate inhibitors
  Others


Distribution Channel

  Hospital pharmacies
  Retail pharmacies
  Online pharmacies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    Spain
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Application Insights

The movement disorders segment is estimated to witness significant growth during the forecast period. Movement disorders, including conditions such as balance problems, Parkinson's disease, Huntington's disease, spinal muscular atrophy, multiple sclerosis, c

Background: Stroke is a devastating disease, but it is treatable with alteplase or tissue plasminogen activator (tPA). The effectiveness of tPA is highly time-dependent, meaning rapid treatment is critical. Fast treatment with tPA has been reported in many urban hospitals, but hospitals in rural locations struggle to reduce treatment times. This qualitative study examines current thrombolysis processes in one urban and two rural hospitals in Nova Scotia, Canada, by mapping and comparing the treatment process in these settings for acute ischemic stroke (AIS) patients, and by analyzing the healthcare professionals views on various treatment topics.Methods: Structured interviews were conducted with healthcare professionals involved in stroke treatment across the three sites. The interviews focused on the various activities in the thrombolysis treatment at each site. Additionally, participants were asked about the following 10 topics: comfort treating acute ischemic stroke patients; perceptions about tPA; appropriate tPA treatment window; stroke patient priority; tPA availability; patient consent; urban-rural treatment differences; efficiency of their treatment process; treatment delays; and suggested process improvements. Results were analyzed using the Framework Method, as well as through the development of process maps.Results: Twenty three healthcare professionals were interviewed at 2 rural hospitals and 1 urban hospital. Acute ischemic stroke patients are triaged as the highest or urgent priority at each included site. Physicians are more hesitant to treat with tPA in rural settings. A total of 11 urban-rural treatment differences were noted by the rural sites. Additionally, 11 patient-related and 29 system treatment delays were described. A process map was developed for each site, representing the arrival by ambulance and by private vehicle pathways.Conclusions: Guidelines and clear protocols are critical in reducing treatment times and ensuring consistent access to treatment. The majority of treatment delays encountered are system delays, which can be appropriately planned for to reduce delays within the care pathway. There is a general consensus that there is an urban-rural treatment gap for acute ischemic stroke patients in Nova Scotia, and that continuing education is key in rural hospitals to improve Emergency Department (ED) physician comfort with treating patients with tPA.

Snapshot img

Electric Wheelchairs Market Size 2024-2028

The electric wheelchairs market size is forecast to increase by USD 2.59 billion at a CAGR of 13.64% between 2023 and 2028. The Electric Wheelchairs Industry is experiencing significant growth due to the increasing prevalence of chronic diseases and disabilities among the elderly population and individuals with muscle disorders. Hospitals and health institutes are increasingly adopting electric wheelchairs as essential healthcare facilities equipment to enhance patient mobility and improve overall care. The trend towards front-wheel-electric wheelchairs is gaining popularity due to their maneuverability and ease of use. However, the high cost of electric wheelchairs remains a significant challenge for many consumers, limiting their access to this essential mobility solution. The market is expected to continue growing as the aging population and those with disabilities require more advanced and accessible mobility solutions.

Request Free Sample

The electric wheelchair industry is witnessing significant growth due to the increasing demand from hospitals, health institutes, and the elderly population. Chronic diseases, disabilities, and muscle disorders are driving the market's expansion. The market, which includes battery powered wheelchairs designed for household use, faces technological problems such as product recalls and the need for a robust manufacturing base, while e-commerce sites and online sales channels increasingly leverage pre programmed systems and open stack designs, incorporating features like LED lighting systems to enhance safety in traffic accidents. The healthcare facilities sector is a major consumer of electric wheelchairs, with patients requiring mobility assistance during treatment and rehabilitation. The aging population and younger generation with physical disabilities also contribute to the market's growth. Accidents and sports injuries can lead to temporary or permanent mobility issues, further increasing the demand for electric wheelchairs.

Furthermore, assistive technologies, pre-programmed systems, and wheelchair accessibility solutions are becoming essential in healthcare infrastructure. E-commerce sites and home delivery services have made electric wheelchairs more accessible to consumers. The market for personal mobility devices, including electric wheelchairs, is expected to grow as the younger generation seeks mobility assistance. Neuromuscular conditions and other muscle disorders are also fueling the demand for these devices. In summary, the market is poised for growth, driven by the healthcare sector, aging population, and increasing awareness of mobility assistance devices. The market's expansion is a testament to the importance of medical technology and healthcare infrastructure in addressing the mobility needs of patients and individuals with disabilities.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Personal
  Hospitals
  Sports conditioning


Product

  Dry-battery electric wheelchairs
  Wet-battery electric wheelchairs


Geography

  North America

    Canada
    US


  Europe

    Germany
    France


  Asia

    Japan


  Rest of World (ROW)

By End-user Insights

The personal segment is estimated to witness significant growth during the forecast period. Electric wheelchairs offer young age people with mobility challenges the freedom and convenience to move around with ease and independence. These personal mobility devices, also known as power wheelchairs, are particularly beneficial for individuals who have experienced accidents or have permanent disabilities. Electric wheelchairs are equipped with pre-programmed systems, allowing users to control their movement with a joystick or a push of a button, making them ideal for both indoor and outdoor use. Comfort is a crucial factor in the selection of an electric wheelchair.

Furthermore, these assistive technologies are designed with ergonomic seats and backrests, ensuring comfort during extended periods of use. With the rise of e-commerce sites and home delivery services, purchasing an electric wheelchair has become more accessible than ever before.

Get a glance at the market share of various segments Request Free Sample

The personal segment was valued at USD 929.90 million in 2018 and showed a gradual increase during the forecast period.

Regional Insights

North America is estimated to contribute 53% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Reques

Diabetes continues to be a significant global health concern, with the Western Pacific region reporting the highest number of diabetes-related deaths in 2024, with around 1.2 million. This stark figure underscores the urgent need for improved diabetes prevention and management strategies worldwide. North America and the Caribbean followed with an estimated 526,000 deaths, while Africa is had the lowest number at 216,000. Regional disparities and global impact The prevalence of diabetes varies significantly across regions, reflecting differences in healthcare systems, lifestyle factors, and genetic predispositions. In the United States, the death rate from diabetes mellitus was 22.4 per 100,000 people in 2023, with 8.4 percent of the adult population living with the condition. Canada has seen a slight decrease in its diabetes-related death rate, falling from 21.8 per 100,000 in 2000 to 18.1 per 100,000 in 2023. These figures highlight the ongoing challenges in managing diabetes, even in countries with advanced healthcare systems. European landscape and global context Within Europe, Germany reported the highest number of diabetes-related deaths in 2024, with nearly 63,000 fatalities among adults aged 20 to 79 years. Italy followed closely with around 62,400 deaths. However, Czechia reported the highest mortality rates in Europe as of 2022, with 43.4 diabetes deaths per 100,000 population overall. On a global scale, diabetes remains a major health concern, with 19 percent of adults worldwide identifying it as one of the biggest health problems in their country.